Showing 1 - 2 of 2 results for "07903"
- ReferenceYang L et al. ( 2014) Current Protocols in Molecular Biology 107 31.1.1----17
CRISPR/Cas9-Directed Genome Editing of Cultured Cells.
Human genome engineering has been transformed by the introduction of the CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) system found in most bacteria and archaea. Type II CRISPR/Cas systems have been engineered to induce RNA-guided genome editing in human cells, where small RNAs function together with Cas9 nucleases for sequence-specific cleavage of target sequences. Here we describe the protocol for Cas9-mediated human genome engineering, including construct building and transfection methods necessary for delivering Cas9 and guide RNA (gRNA) into human-induced pluripotent stem cells (hiPSCs) and HEK293 cells. Following genome editing, we also describe methods to assess genome editing efficiency using next-generation sequencing and isolate monoclonal hiPSCs with the desired modifications for downstream applications. View PublicationCatalog #: Product Name: 07903 0.1% Gelatin in Water 85850 mTeSR™1 Catalog #: 07903 Product Name: 0.1% Gelatin in Water Catalog #: 85850 Product Name: mTeSR™1 - ReferenceDiederichs S and Tuan RS (JUL 2014) Stem cells and development 23 14 1--53
Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor.
Mesenchymal stem cells (MSCs) have a high potential for therapeutic efficacy in treating diverse musculoskeletal injuries and cardiovascular diseases, and for ameliorating the severity of graft-versus-host and autoimmune diseases. While most of these clinical applications require substantial cell quantities, the number of MSCs that can be obtained initially from a single donor is limited. Reports on the derivation of MSC-like cells from pluripotent stem cells (PSCs) are, thus, of interest, as the infinite proliferative capacity of PSCs opens the possibility to generate large amounts of uniform batches of MSCs. However, characterization of such MSC-like cells is currently inadequate, especially with regard to the question of whether these cells are equivalent or identical to MSCs. In this study, we have derived MSC-like cells [induced PSC-derived MSC-like progenitor cells (iMPCs)] using four different methodologies from a newly established induced PSC line reprogrammed from human bone marrow stromal cells (BMSCs), and compared the iMPCs directly with the originating parental BMSCs. The iMPCs exhibited typical MSC/fibroblastic morphology and MSC-typical surface marker profile, and they were capable of differentiation in vitro along the osteogenic, chondrogenic, and adipogenic lineages. However, compared with the parental BMSCs, iMPCs displayed a unique expression pattern of mesenchymal and pluripotency genes and were less responsive to traditional BMSC differentiation protocols. We, therefore, conclude that iMPCs generated from PSCs via spontaneous differentiation represent a distinct population of cells which exhibit MSC-like characteristics. View PublicationCatalog #: Product Name: 07923 Dispase (1 U/mL) 07903 0.1% Gelatin in Water 85850 mTeSR™1 Catalog #: 07923 Product Name: Dispase (1 U/mL) Catalog #: 07903 Product Name: 0.1% Gelatin in Water Catalog #: 85850 Product Name: mTeSR™1
Shop By
Filter Results
Filters:
- Resource Type Reference Remove This Item
- Clear All
- Area of Interest
-
- Stem Cell Biology 2 items
- Brand
-
- TeSR 2 items
- Cell Type
-
- Mesenchymal Stem and Progenitor Cells 1 item
- Pluripotent Stem Cells 2 items